SecSonar.com

Neuphoria Therapeutics Inc. (NEUP)

Neuphoria Therapeutics Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Neuphoria Therapeutics Inc. (NEUP) is a Medical - Pharmaceuticals company based in US with a market capitalization of $28.6M. The company generated $77.2M in free cash flow. This page tracks NEUP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 8 employees · IPO Dec 16, 2021

Valuation

Valuation & price

$4.73 · as of May 17, 2026 · -76.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.99

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$20.00$11.69$3.38Jul 25Dec 25Jul 26Jul 7, 25$7.16Jul 9, 25$7.46Jul 11, 25$7.69Jul 15, 25$7.56Jul 17, 25$7.49Jul 21, 25$7.70Jul 23, 25$8.20Jul 25, 25$8.50Jul 29, 25$8.56Jul 31, 25$8.11Aug 4, 25$7.78Aug 6, 25$7.84Aug 11, 25$7.20Aug 13, 25$7.95Aug 15, 25$8.10Aug 19, 25$7.64Aug 21, 25$6.92Aug 25, 25$7.34Aug 27, 25$10.22Aug 29, 25$11.33Sep 3, 25$13.00Sep 5, 25$11.89Sep 9, 25$15.10Sep 11, 25$13.99Sep 16, 25$12.51Sep 18, 25$9.40Sep 22, 25$9.86Sep 24, 25$11.45Sep 26, 25$12.31Sep 30, 25$11.79Oct 2, 25$14.64Oct 6, 25$20.00Oct 8, 25$18.37Oct 10, 25$17.50Oct 14, 25$16.05Oct 16, 25$15.17Oct 21, 25$4.85Oct 23, 25$4.05Oct 27, 25$4.53Oct 29, 25$4.58Oct 31, 25$4.55Nov 4, 25$4.22Nov 6, 25$4.28Nov 10, 25$4.90Nov 12, 25$4.90Nov 14, 25$4.79Nov 18, 25$4.74Nov 20, 25$4.21Nov 25, 25$4.56Nov 28, 25$4.52Dec 2, 25$4.37Dec 4, 25$4.27Dec 8, 25$4.54Dec 10, 25$4.21Dec 12, 25$4.08Dec 16, 25$3.90Dec 18, 25$3.89Dec 22, 25$3.91Dec 24, 25$3.79Dec 29, 25$3.77Jan 2, 26$3.82Jan 6, 26$3.98Jan 8, 26$4.07Jan 12, 26$4.20Jan 14, 26$4.04Jan 16, 26$4.11Jan 21, 26$4.04Jan 23, 26$4.19Jan 27, 26$4.05Jan 29, 26$4.02Feb 2, 26$4.04Feb 4, 26$4.00Feb 9, 26$4.00Feb 11, 26$4.01Feb 13, 26$4.05Feb 18, 26$4.42Feb 20, 26$4.35Feb 24, 26$4.39Feb 26, 26$4.36Mar 2, 26$4.26Mar 4, 26$4.64Mar 6, 26$4.32Mar 10, 26$4.65Mar 12, 26$4.73Mar 17, 26$4.61Mar 19, 26$4.40Mar 23, 26$4.61Mar 25, 26$4.37Mar 27, 26$4.10Mar 31, 26$4.07Apr 2, 26$4.41Apr 7, 26$4.60Apr 9, 26$4.72Apr 13, 26$4.57Apr 15, 26$4.65Apr 17, 26$4.77Apr 22, 26$4.93Apr 24, 26$5.04Apr 28, 26$5.12Apr 30, 26$5.27May 4, 26$5.29May 6, 26$5.38May 8, 26$5.31May 12, 26$4.93May 14, 26$5.09May 18, 26$4.72May 20, 26$4.93May 22, 26$5.48May 28, 26$5.36Jun 1, 26$5.30Jun 3, 26$4.70Jun 5, 26$4.49Jun 9, 26$4.66Jun 11, 26$4.49Jun 15, 26$4.29Jun 17, 26$4.31Jun 22, 26$4.44Jun 24, 26$4.49Jun 26, 26$4.57Jul 2, 26$3.38
$3.3852-week range$20.00
Loading valuation history…

Fundamentals

Key fundamentals

$28.6M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

$77.2M

Free cash flow (USD)

-$21.4M

Net debt

Net cash position

-98.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$5.2MFY 2017$4.1MFY 2018$2.8MFY 2019$2.7MFY 2020$32.1KFY 2021$0.00FY 2022$263.6KFY 2023$0.00FY 2024$0.00FY 2025$15.6M
$5.2M$15.6M

Free cash flow by year

2016 → 2025

FY 2016$-15.5MFY 2017$-1.6MFY 2018$-15.4MFY 2019$-11.0MFY 2020$-2.7MFY 2021$-5.7MFY 2022$-15.0MFY 2023$-9.8MFY 2024$-14.7MFY 2025$77.2M
-$15.5M$77.2M

Gross margin by year

2022 → 2025

FY 2022100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.09)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventRevenue Distribution ReceivedMay 26, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing

Questions

Frequently asked questions

What is Neuphoria Therapeutics Inc.'s market cap?

Neuphoria Therapeutics Inc. (NEUP) has a market capitalization of $28.6M.

What is NEUP's P/E ratio?

A meaningful P/E ratio is not available for NEUP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is NEUP's price-to-book (P/B) ratio?

NEUP trades at 0.99 times book value per share.

When did Neuphoria Therapeutics Inc. last report earnings?

NEUP last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying NEUP stock?

SEC Form 4 filings show no open-market insider buys at Neuphoria Therapeutics Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Pharmaceuticals

KYNB

Kyntra Bio, Inc.

$28.1M

SDEV

Stablecoin Development Corp.

$35M

POM

POMDOCTOR Ltd

$12.7M

PETS

PetMed Express, Inc.

$46.7M

YI

111, Inc.

$47.9M

HKPD

Cellyan Biotechnology Co., Ltd

$5.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.